QUIA PHARMA AB
Develops medicines using a proprietary drug delivery platform to improve efficacy.
QUIA | ST
Overview
Corporate Details
- ISIN(s):
- SE0020678159
- LEI:
- 967600JUP7EI6X9D2Z44
- Country:
- Sweden
- Address:
- Virdings Allé 32 B, 754 50 Uppsala
- Website:
- https://www.quiapeg.com/
Description
QUIA PHARMA AB is a pharmaceutical development company focused on the research, development, and commercialization of medicines. The company's core activity is based on its proprietary and patented drug delivery platform, Uni-Qleaver®. This platform utilizes a unique, releasable pegylation technology designed to improve the properties of drugs by temporarily modifying them. The Uni-Qleaver® technology aims to enhance the therapeutic efficacy and safety profile of pharmaceuticals by extending their duration of action and enabling the release of the active drug in its original, unmodified form. The company applies this platform to develop improved and patentable versions of existing drugs as well as new chemical entities, with a focus on therapeutic areas such as endocrinology and metabolic diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all QUIA PHARMA AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for QUIA PHARMA AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for QUIA PHARMA AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
